Dynogen Pharmaceuticals

5HT3 receptor-targeted drugs for bowel syndromes

placeBoston, Massachusetts, United States language dynogen.com

Innovation

34 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 806 times.

YearFilings
20121

Investor mix

8 investors on record.

Investor typeCountShare
Other / undisclosed8100%
Coming soon